The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients.

Albaker, Waleed; Al Sheikh, Mona; Albakr, Aishah; Alkhafaji, Dania; Al Besher, Eman; Al-Hariri, Mohammed

Albaker, Waleed; Al Sheikh, Mona; Albakr, Aishah; Alkhafaji, Dania; Al Besher, Eman; Al-Hariri, Mohammed.

Afiliación

Albaker W; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Al Sheikh M; Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Albakr A; Department of Neurology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Alkhafaji D; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Al Besher E; Department of Family Medicine, Ministry of Health, Dammam, Saudi Arabia.
Al-Hariri M; Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Int J Gen Med ; 14: 8643-8650, 2021.

Article en En | MEDLINE | ID: mdl-34849008

Palabras clave

Liraglutide; Saudi; obesity; weight loss

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Int J Gen Med Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google